@article{b627f20ee84f4a2ba549473dabf55243,
title = "Biologics, spondylitis and COVID-19",
keywords = "biological therapy, communicable diseases, imported, methotrexate, spondylitis, ankylosing, therapeutics",
author = "Rosenbaum, {James Todd} and Hedley Hamilton and Dongseok Choi and Weisman, {Michael H.} and Reveille, {John D.} and Winthrop, {Kevin L.}",
note = "Funding Information: Funding The Spondylitis Association of America has provided support for this project. JTR receives support from the Grandmaison Fund for Autoimmunity Research, the William and Mary Bauman Foundation, the Stan and Madelle Rosenfeld Family Trust and Research to Prevent Blindness. Funding Information: Competing interests JTR: consultant for Abbvie, Gilead, Novartis, UCB, Roche, Horizon, Corvus, Eyevensys; grant support: Pfizer, Horizon; Royalties: UpToDate. HH: owns Any-3. DC: none. MHW: consults: Novartis, UCB, Gilead, GSK. JR: consults: Novartis, UCB, Gilead, GSK. KLW: consults: Pfizer, Abbvie, UCB, Lilly, Galapagos, GSK, Roche, Gilead; research support: BMS, Pfizer.",
year = "2020",
month = dec,
day = "1",
doi = "10.1136/annrheumdis-2020-217941",
language = "English (US)",
volume = "79",
pages = "1663--1665",
journal = "Annals of the rheumatic diseases",
issn = "0003-4967",
publisher = "Elsevier BV",
number = "12",
}